Effect of sulphadoxine-pyrimethamine co-administration on pharmacokinetics of alpha beta arteether, an anti-malarial agent, in healthy male volunteers

Central Drug research Institute lucknow0 个研究点目标入组 12 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Willing to give written, informed consent prior to inclusion in the study
•2. Willing to comply with protocol requirements, ability to comprehend the full nature and purpose of the study, including possible risks and side effects; and to comply with the requirements of the entire study
•3. Normal physical & systemic examination
•4. No abnormality detected on X-ray chest & ECG
•5. No laboratory evidence of hepatic, renal or cardiac dysfunction

•1.Are on any form of medication, smokers or who have consumed tobacco, alcohol, grapefruit juice during a period of 7 days before the study.
•2. History of any drug taken in past 15 days.
•3. Have been treated with any known enzyme inducing or inhibiting drugs within 30 days of the study.
•4.Suffering from any chronic disease which is likely to interfere with the metabolism/evaluation of test drugs.
•5. History of participation in any clinical trial in last three months
•6.Patients on treatment with corticosteroids, anti-convulsants, bronchodilators, etc.

发起方

Central Drug research Institute lucknow